iShares Genomics Immunology and Healthcare ETF

1. 01

   Set a 52-week high on 4 Nov 2026

   Closed at $44.15 on 4 Nov 2026: 0.0% below the 52-week high of $44.15 (4 Nov 2026) and 81.8% above the low of $24.29 (7 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY over 1 year

   1 month: +8.0% (SPY −1.6%). 3 months: +32.4% (SPY −0.4%). 1 year: +79.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: IDNA, SPY · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $44.15 was 7.8% above its 50-day average ($40.96) and 32.0% above its 200-day average ($33.45). It has closed above the 200-day for 310 sessions, since 13 Aug 2025. The 50-day average crossed above the 200-day on 5 Sep 2025, 293 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   Volume 1.8× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 322.7K shares was 1.8× the average of the 30 sessions before it (179.4K), as the price rose 4.0%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

5. 05

   Short interest at 0.9% of shares outstanding

   67.9K shares were sold short at the 15 Oct 2026 settlement, 0.9% of the 7.8M shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close